External Reference Standards or Relative Response Factors: Considerations for Quantitation of Impurities in Pharmaceuticals
Accurate and reproducible quantitation of impurities in pharmaceuticals is an important part of drug development. Impurities must be controlled to levels that will ensure the quality of the product is as good or better than the quality of materials used in preclinical safety studies and clinical tri...
Saved in:
Main Author: | article Editorial |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2021-08-01
|
Series: | Разработка и регистрация лекарственных средств |
Online Access: | https://www.pharmjournal.ru/jour/article/view/991 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genotoxic Impurities in Pharmaceuticals
by: Jouyban, Abolghasem, et al.
Published: (2012) -
End-to-end Standardization of Original Medicines when Determining Related Impurities
by: Yu. E. Generalova, et al.
Published: (2023-12-01) -
Nonspecific Impurities in Pharmaceutical Substances: Characteristics of Test Methods
by: Yu. R. Biglova, et al.
Published: (2019-09-01) -
FORECASTING AND EXPERIMENTAL DETERMINATION OF DESTRUCTION IMPURITIES AND IN THE PHARMACEUTICAL COMPOSITION OF THE HYPOTENSIVE ACTION
by: E. V. Kompantseva, et al.
Published: (2015-09-01) -
Current approaches to the control of process-related impurities in antibiotics
by: E. L. Kovaleva, et al.
Published: (2024-12-01)